Cemented dual mobility component in newly implanted porous tantalum shells for severe acetabular defects: medium-term outcomes from a high-volume single-surgeon series Authors: Mattia Loppini, Vincenzo Di Matteo, Alberto Bulgarelli, Francesco La Camera, Katia Chiappetta, Emanuela Morenghi, Guido Grappiolo Published: 2026 ABSTRACT BackgroundThe management of severe acetabular bone defects remains challengin due to extensive bone loss and poor soft tissue quality during revision total hip arthroplasty (rTHA). The aim of this study was to assess clinical and radiological outcomes of the use of dual mobility components (DMC) cemented into a newly implanted porous tantalum (PT) acetabular shell during acetabular rTHA.MethodsPatients who underwent cementation of a DMC into a newly implanted PT cup between 2014 and 2020 were included. Bone defects were classified according to the Paprosky classification. The primary outcome was to determine the reintervention-free survival rate. The secondary outcome was clinical and radiographic assessment at last follow-up.ResultsThirty-six patients (36 hips), with an average age of 67.9 years (range, 46–90) were included. Paprosky type III defects (61.1%) were more common than type II defects (38.9%), with type IIIa (36.1%) and IIIb (25.0%) predominating. Median follow-up was 67.3 months (range; 17–109). The dislocation rate was 8.3% (n = 3). Four (11.1%) of 36 hips underwent acetabular component revision: 2 (5.5%) for infections, 1 (2.7%) for aseptic loosening, and 1 (2.7%) for dislocation. Cup survival rate was 89.08% (CI 69.54% to 96.38%) at 60 months. The Harris hip score (HHS) improved from 31.8 ± 12.0 to 87.0 ± 14.2 points (p < 0.001). The vertical and horizontal position of the hip center of rotation (COR) improved from 19.4 ± 14.9 mm to 3.8 ± 3.4 mm and from 12.4 ± 9.9 mm to 3.8 ± 3.5 mm, respectively (both p < 0.001). Limb length discrepancy improved from − 7.8 ± 20.6 mm to -1.7 ± 5.6 mm (p = 0.056).ConclusionsDMCs cemented into PT shells could be considered an effective management of severe acetabular bone defects without pelvic discontinuity providing excellent clinical and radiographic results in the mid-term. Introduction The primary goals of revision total hip arthroplasty (rTHA) are managing acetabular bone loss and addressing a compromised soft tissue envelope. Instability stands as one of the primary indications for rTHA and re-revision THA, with reported incidence ranging from 6.6% to 28.0% among all rTHA patients [1–9]. Non-cemented hemispheric porous tantalum (PT) shells are used, with or without augments, in case of moderate-to-severe acetabular bone defects to allow biological fixation while providing coverage and mechanical support [10, 11]. Still, bone loss can condition cup positioning and shift the center of rotation (COR), altering cup orientation and ultimately leading to a higher dislocation risk. The use of a dual mobility component (DMC) ensures higher hip implant stability both in primary complex THA and rTHA [12]. The DMC design incorporates two mobile articulations, which increase the effective head diameter and thereby extend the impingement-free range of motion [13]. Furthermore, in patients undergoing acetabular revision where implant placement often depends on residual bone stock, the possibility of cementing a DMC into a newly implanted PT cup allows to further optimize the location of the COR, cup anteversion, and abduction independent of the exact position achieved by the press-fit shell [14, 15]. A DMC cemented into a newly implanted PT cup not only diminishes the likelihood of dislocation following high complexity r-THAs, but also improves mechanical stability, displaying no evidence of acetabular migration over the short and medium term [14, 15]. Although some authors have already investigated the use of DMCs cemented in PT cups in this setting [14, 15], existing studies are limited by short follow-up and heterogenous populations drawn from multiple centers and treated by different surgeons. To our knowledge, the existing literature lacks studies examining mid-term outcomes of DMCs cemented into newly implanted PT shells in a single-surgeon, high-volume, single-center setting. The primary goal of this study was to analyze reintervention-free survival rate of complex rTHAs performed with DMC cemented into newly implanted highly porous tantalum shells in a single high-volume tertiary-referral center. The secondary intended outcome was to determine clinical and radiographic outcomes at the time of follow-up. Materials and methods The study protocol for the development of this registry was approved on 18 December 2017 by the Ethics Committee of IRCCS Humanitas Research Hospital (protocol code 618/17). All individual participants signed written informed consent for surgery and study participation. All acetabular revisions performed between September 2014 and September 2020 by a single senior orthopedic surgeon were assessed. Patients who underwent acetabular revision with a DMC cemented into a newly implanted PT cup were enrolled. Patients aged above 18 years old with a minimum follow-up of 24 months were included. Age at surgery, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) score, number of previous hip surgeries, and cause for revision were retrospectively obtained from electronic medical records. Clinical and surgical records, follow-up visits, and radiographic evaluations of all patients were reviewed. All preoperative radiographs (i.e., standing anterioposterior view of the pelvis and Lowenstein lateral view of the hip) were obtained and analyzed by two observers which were not involved in the surgery of these patients. Acetabular bone defects were rated using the Paprosky Classification, with disagreements resolved using the intraoperative description of the defect [10]. The following surgical variables were collected: strategy employed (rTHA or isolated acetabular revision), operative duration (minutes), tantalum shell size, DMC size, femoral head size, and use of concomitant acetabular cages, augments, screws, or bone grafts. Complications such as dislocation, intraprosthetic dislocation (IPD), loosening, periprosthetic hip fracture (PPHF) and periprosthetic joint infection (PJI) were analyzed. Reinterventions at 1 year, 2 years, 3 years, 5 years and mortality rate were recorded. Clinical and radiographic evaluations were performed before and immediately after surgery, and 1, 3, 6, 12 months, 2 years and 5 years from surgery. Clinical evaluation included physical examination, with measurement of range of motion (ROM) and Harris Hip Score (HHS). The assessment of ROMs was performed with an universal goniometer according to standard measurement guidelines [16]. The preoperative and postoperative limb length discrepancy (LLD) was evaluated with digital radiographs in AP view of the pelvis by using the Hip Arthroplasty Templating 2.4.3 software (OsiriX v.5.8.1 64-bit; Pixmeo SARL; Bernex, Switzerland) according to the methodology described in a previous publication by our group and by Ranawat et al. [17, 18]. The measurements were performed using the ischium and lesser trochanter as landmarks. The preoperative and postoperative COR positions in the vertical axis and horizontal axis from the inferior and medial border of teardrop were respectively measured. Postoperative radiographs were assessed for radiographic signs of loosening, including: osteolysis; migration exceeding 6 mm superiorly or inferiorly (vertical plane) or 6 mm medially or laterally (horizontal plane) from the immediate postoperative position; a change greater than 10° in cup abduction angle or gross cup migration; screw breakage; or radiolucent lines involving > 30% of the bone-implant interface [19]. Surgical technique All patients received perioperative antibiotic prophylaxis with Cefazolin 2 g IV at induction of anesthesia, repeated every 8 h for a total of 4 doses per institutional protocol. A standard posterolateral approach to the hip was used in all cases. All patients underwent acetabular revision with cementation of a dual mobility liner that is intended for insertion with cement (Avantage®; Zimmer Biomet, Warsaw, IN, USA), into a newly implanted porous tantalum revision shell (Trabecular Metal® Acetabular Revision System; Zimmer Biomet, Warsaw, IN, USA). Sequential reaming of the acetabulum was performed to achieve maximal engagement of the trial cup with host pelvic bone. Morselized bone autograft from acetabular reaming, synthetic bone grafts, or augments were used when necessary to fill acetabular bone defects. A porous tantalum cup of appropriate size was press-fit into the acetabulum. If the impacted acetabular shell did not achieve an adequate press-fit against the host bone, supplemental screws and/or an acetabular cage (TMARS®; Zimmer Biomet, Warsaw, IN, USA) were used to obtain proper primary stability. Cup positioning, including COR shift, abduction, and anteversion, was dictated by the extent of acetabular bone loss and the amount of residual host bone available to achieve a stable press-fit. After removal of the femoral head, stem stability was assessed intraoperatively by applying manual axial and rotational stress to the exposed trunnion. A stem was considered loose, and a complete stem revision was performed, when macroscopic movement was observed at the bone-implant interface for cementless stems or debonding or motion of the entire cement mantle for cemented stems [20]. When stem revision was required, stem choice was made depending on bone defect and integrity of the metaphysis, and presence or absence of a stable cement mantle. In hips with minimal bone loss and a preserved metaphysis, a primary uncemented stem (GTS®; Zimmer Biomet, Warsaw, IN, USA) was used [21]. Similarly, in hips with a stable cement mantle, the existing femoral component was re-cemented in situ. Finally, in hips with metaphyseal compromise and/or extensive proximal bone loss, either a modular tapered stem (Arcos Modular Femoral Revision System®; Zimmer Biomet, Warsaw, IN, USA) or a monoblock tapered conical stem with longitudinal ribs (Wagner SL Revision®; Zimmer Biomet, Warsaw, IN, USA) was used [22]. Modular components were retained in all well-fixed modular revision stems. As a rule, the femoral head was always exchanged irrespective of whether the stem was retained or revised. To enhance coupling on a potentially damaged taper, either a metal head (cobalt-chromium VerSys® Hip System, Zimmer Biomet, Warsaw, IN, USA; or stainless-steel Protasul-S30, Zimmer GmbH, Winterthur, Switzerland) or a ceramic revision head mounted on a titanium adapter sleeve (BIOLOX®OPTION; CeramTec GmbH, Plochingen, Germany) was implanted according to the patient’s age and activity level. A modular head–neck adapter (BioBall® Modular Head System; Merete Medical GmbH, Berlin, Germany) was interposed between the retained trunnion and the new femoral head when further intraoperative adjustment of offset, varus/valgus, or anteversion/retroversion was required to optimize hip biomechanics. Polymethylmeth-acrylate cement antibiotic-loaded (Refobacin® Plus Bone Cement, Zimmer Biomet, Warsaw, IN, USA) was hand-mixed and placed in the internal surface of the TM cup. When the cement had reached a doughy consistency, the DMC was impacted into the PT shell. Cup size was selected according to a standardized criterion. In each case, the largest cup preserving an even circumferential cement mantle of approximately 2 mm was selected (i.e., a difference of at least 10 mm between the outer diameters of the shell and cup) to optimize stress transfer across the cement while maximizing the effective bearing diameter [23]. During cementation of the DMC, placement of the liner was fined tuned to restore the original COR vertical and horizontal distances, with the abduction and anteversion of the DMC chosen compliant to the stem in order to achieve the correct combined anteversion between cup and stem [24]. Postoperative radiographs confirmed adequate positioning of the components. Thromboprophylaxis consisted of Enoxaparin 4000 IU subcutaneously once daily, initiated 8 h postoperatively and continued until full weight-bearing, in accordance with institutional protocol. Postoperative antiresorptive therapy was not routinely administered as part of our protocol. When indicated, bone quality was optimized preoperatively through medical management of osteoporosis. The patients were allowed to stand on the second postoperative day, and to walk with crutches and a 50% of weight-bearing. During the first 2 months following the surgery, patients underwent a physical rehabilitation program to progressively increase abductor resistance and weight-bearing. Patients were allowed to walk full weight-bearing without crutches 2 months after surgery. Data analyses Categorical variables were described as numbers and percentages, and continuous variables as mean, standard deviation, and range. Adherence of continuous variables to a Gaussian distribution was assessed using the Shapiro-Wilk test. Changes in continuous variables between pre-surgery and last follow-up were evaluated using the Wilcoxon signed-rank test, given the non-Gaussian distribution of the data. Reintervention-free survival time was calculated from the date of surgery to the date of reintervention for patients who underwent additional revision procedures, or to the date of last contact for those who remained reintervention-free. Reintervention-free survival was estimated using the Kaplan-Meier method and plotted with the corresponding 95% confidence interval (CI). Reintervention-free survival for any reason was estimated at 1, 2, 3, and 5 years, with results reported as percentages with 95% CI. All analyses were performed using Stata version 18 (StataCorp, College Station, TX). A p-value < 0.05 was considered statistically significant. Results Demographics One thousand and twenty-seven hips (1027 patients) undergoing acetabular revision arthroplasty were retrospectively reviewed and 36 hips (36 patients) in whom a DMC was cemented into a newly implanted porous tantalum shell were enrolled. Aseptic cup loosening was the most frequent indication for rTHA, affecting 30 patients (83.3%). Paprosky type III defects (61.1%) were more common than type II defects (38.9%), with type IIIa (36.1%) and IIIb (25.0%) predominating. No included patient had pelvic discontinuity. Baseline characteristics of the population are described in Table 1. Table 1Population baseline characteristicsN36Age at surgery (years)67.9 (46–90)Gender (Male)15 (41.7%) Body Mass Index (BMI) BMI < 19 kg/m2 (underweight)2 (5.5%)BMI 19–24.9 kg/m2 (normal weight)11 (30.6%)BMI 25–29.9 kg/m2 (overweight)20 (55.6%)BMI 30–34.9 kg/m2 (class I obesity)3 (8.3%) ASA score ASA score I4 (11.1%)ASA score II27 (75.0%)ASA score III5 (13.9%) Number of previous arthroplasty procedures 120 (55.5%)210 (27.7%)33 (8.3%)43 (8.3%) Diagnosis Aseptic Loosening30 (83.3%) Acetabular Loosening23 (63.9%) Acetabular and Stem Loosening7 (19.4%)Dislocation3 (8.3%)Infection2 (5.6%)Periprosthetic Fracture1 (2.8%) Acetabular Defects (Paprosky) I0 (0.0%)IIa6 (16.6%)IIb6 (16.6%)IIc2 (5.6%)IIIa13 (36.1%)IIIb9 (25.0%)Pelvic discontinuity0 (0.0%)BMI Body mass index, ASA American society of anesthesiologists Table 1Population baseline characteristicsN36Age at surgery (years)67.9 (46–90)Gender (Male)15 (41.7%) Body Mass Index (BMI) BMI < 19 kg/m2 (underweight)2 (5.5%)BMI 19–24.9 kg/m2 (normal weight)11 (30.6%)BMI 25–29.9 kg/m2 (overweight)20 (55.6%)BMI 30–34.9 kg/m2 (class I obesity)3 (8.3%) ASA score ASA score I4 (11.1%)ASA score II27 (75.0%)ASA score III5 (13.9%) Number of previous arthroplasty procedures 120 (55.5%)210 (27.7%)33 (8.3%)43 (8.3%) Diagnosis Aseptic Loosening30 (83.3%) Acetabular Loosening23 (63.9%) Acetabular and Stem Loosening7 (19.4%)Dislocation3 (8.3%)Infection2 (5.6%)Periprosthetic Fracture1 (2.8%) Acetabular Defects (Paprosky) I0 (0.0%)IIa6 (16.6%)IIb6 (16.6%)IIc2 (5.6%)IIIa13 (36.1%)IIIb9 (25.0%)Pelvic discontinuity0 (0.0%)BMI Body mass index, ASA American society of anesthesiologists Population baseline characteristics BMI Body mass index, ASA American society of anesthesiologists Clinical and radiographic results Isolated acetabular revision was performed in the majority of patients (24/36, 66.7%). While the median porous tantalum shell outer diameter was 62 mm (range 56–70), the median DMC outer diameter size was 48 mm (range 44–54). The inner femoral head was 28 mm in 26 hips (72.2%) and 22 mm in 10 hips (27.8%). Cobalt-chromium heads were used in 28 hips (77.8%) and ceramic heads with a titanium adapter sleeve in 8 hips (22.2%). A modular head–neck adapter (BioBall®) was used in 3 hips (8.3%) to further adjust offset and version of the retained trunnion (Fig. 1). Additional screws were used in 29 patients (80.5%). In 5 cases, an acetabular cage was used as an adjunct to enhance primary stability when a satisfactory press-fit of the shell could not be achieved intraoperatively despite the absence of pelvic discontinuity (Fig. 2). Surgical details are described in Table 2. Fig. 1Pre- (A) and postoperative (B) radiograph at 4-year follow-up of a 59-year-old patient undergoing revision hip arthroplasty for acetabular cup mobilization, with periprosthetic soft tissue metallosis secondary to neck-cup impingement, marked polyethylene wear, and Paprosky type 2B bone defect. The acetabular component was revised with a 62 mm tantalum revision shell stabilized with 3 screws, with synthetic bone graft placed at the defect base, and a 50 mm dual-mobility liner cemented in place, coupled with a definitive 28 mm L ceramic head with a modular neck adapter Pre- (A) and postoperative (B) radiograph at 4-year follow-up of a 59-year-old patient undergoing revision hip arthroplasty for acetabular cup mobilization, with periprosthetic soft tissue metallosis secondary to neck-cup impingement, marked polyethylene wear, and Paprosky type 2B bone defect. The acetabular component was revised with a 62 mm tantalum revision shell stabilized with 3 screws, with synthetic bone graft placed at the defect base, and a 50 mm dual-mobility liner cemented in place, coupled with a definitive 28 mm L ceramic head with a modular neck adapter Fig. 2Pre- (A) and postoperative (B) radiograph of an 82-year-old patient undergoing revision hip arthroplasty for acetabular cage mobilization with left-sided acetabular protrusio and Paprosky type 3 A bone defect. The acetabular component was revised with a 68 mm tantalum revision shell, short Burch-Schneider cage, and synthetic bone grafts, followed by cementation of a 48 mm dual-mobility cup with a 22 mm C −2 metal head Pre- (A) and postoperative (B) radiograph of an 82-year-old patient undergoing revision hip arthroplasty for acetabular cage mobilization with left-sided acetabular protrusio and Paprosky type 3 A bone defect. The acetabular component was revised with a 68 mm tantalum revision shell, short Burch-Schneider cage, and synthetic bone grafts, followed by cementation of a 48 mm dual-mobility cup with a 22 mm C −2 metal head Table 2Surgery detailsTotal Revision Arthroplasty12 (33.3%)Acetabular Revision24 (66.7%)Side (right)21 (58.3%)Median porous TM shell diameter size62 (56–70)Cemented Avantage Cup48 (44–54)Femoral head diameter 28 mm25 (69.4%)Femoral head diameter 22.2 mm11 (30.6%)Femoral stem revised12 (33.3%)Synthetic bone graft9 (25.0%)Augments12 (33.3%)Screws29 (80.5%)Acetabular cage5 (13.8%)Duration (mins)161 (81–296)TM Trabecular metal Table 2Surgery detailsTotal Revision Arthroplasty12 (33.3%)Acetabular Revision24 (66.7%)Side (right)21 (58.3%)Median porous TM shell diameter size62 (56–70)Cemented Avantage Cup48 (44–54)Femoral head diameter 28 mm25 (69.4%)Femoral head diameter 22.2 mm11 (30.6%)Femoral stem revised12 (33.3%)Synthetic bone graft9 (25.0%)Augments12 (33.3%)Screws29 (80.5%)Acetabular cage5 (13.8%)Duration (mins)161 (81–296)TM Trabecular metal Surgery details TM Trabecular metal No intraoperative complications were reported. Postoperative complications included dislocation (8.3%, n = 3), aseptic cup loosening (2.7%, n = 1), and PJI (5.5%, n = 2). No IPD or PPHF occurred. One patient (2.7%) had two consecutive dislocations treated with closed reduction with an improved HHS at last follow-up. With a mean follow-up of 67.3 (17–109) months, 4 (11.1%) re-revision surgery were performed: 2 (5.5%) for acute PJI requiring two-stage exchange respectively at 41 and 6 months, 1 (2.7%) for acetabular aseptic loosening at 32 months, and 1 (2.7%) for dislocation at 64 months. Overall, Kaplan-Meier analysis estimated freedom from reintervention at 96.77% (95% CI 79.23–99.54%) at both 12 and 24 months, decreasing to 93.32% (95% CI 75.80–98.29%) at 36 months and stabilizing at 89.08% (95% CI 69.54–96.38%) at 60 months (Fig. 3). Fig. 3Kaplan-Meier curve of reintervention free survival Kaplan-Meier curve of reintervention free survival No patients were lost to follow-up. Four (11.1%) unrelated deaths occurred during the follow-up period with the implants unrevised. One patient died of prostate cancer at 19 months of follow-up, one of heart failure at 17 months, one of Sars CoV-19 at 63 months, and one of unknown unrelated causes at 109 months. The average HHS increased from 31.8 ± 12.0 (7–65) to 87.0 ± 14.2 (50–100) at the last follow-up (p < 0.001). The mean vertical position of COR from the interteardrop line changed from 19.4 ± 14.9 (1.3–57.9) mm to 3.8 ± 3.4 (0–12.1) mm postoperatively (p < 0.001). The mean horizontal position of COR from the teardrop changed from 12.4 ± 9.9 (1.8–41.3) mm to 3.8 ± 3.5 (0.4–13.2) mm postoperatively (p < 0.001). The mean preoperative LLD changed from − 7.8 ± 20.6 mm of shortening (−58.8 mm short to 40.5 mm long) on the affected side, to −1.7 ± 5.6 mm of shortening (−18.5 mm short to 6.6 mm long) postoperatively (p = 0.056). Clinical and radiographic outcomes are described in Table 3. Table 3Clinical and radiographic outcomesPreoperativePostoperativep ValueHHS31.8 ± 12.0 (7–65)87.0 ± 14.2 (50–100)<0.001COR vertical distance (mm)19.4 ± 14.9 (1.3–57.9)3.8 ± 3.4 (0–12.1)<0.001COR horizontal distance (mm)12.4 ± 9.9 (1.8–41.3)3.8 ± 3.5 (0.4–13.2)<0.001LLD (mm)−7.8 ± 20.6 (−58.8 to 40.5)−1.7 ± 5.6 (−18.5 to 6.6)0.056Abduction angle (°)48.5 ± 21.0 (8.3–110.3)44.3 ± 7.7 (29.5–62.9)0.239HHS Harris hip score, COR Center of rotation, LLD Limb length discrepancy Table 3Clinical and radiographic outcomesPreoperativePostoperativep ValueHHS31.8 ± 12.0 (7–65)87.0 ± 14.2 (50–100)<0.001COR vertical distance (mm)19.4 ± 14.9 (1.3–57.9)3.8 ± 3.4 (0–12.1)<0.001COR horizontal distance (mm)12.4 ± 9.9 (1.8–41.3)3.8 ± 3.5 (0.4–13.2)<0.001LLD (mm)−7.8 ± 20.6 (−58.8 to 40.5)−1.7 ± 5.6 (−18.5 to 6.6)0.056Abduction angle (°)48.5 ± 21.0 (8.3–110.3)44.3 ± 7.7 (29.5–62.9)0.239HHS Harris hip score, COR Center of rotation, LLD Limb length discrepancy Clinical and radiographic outcomes HHS Harris hip score, COR Center of rotation, LLD Limb length discrepancy At the last follow up visit, 32 (88.9%) implants remained stable and well integrated. Postoperative outcomes are described in Table 4. Table 4Postoperative outcomesDislocation3 (8.3%)Aseptic loosening1 (2.7%)Periprosthetic fracture0 (0.0%)Periprosthetic joint Infection2 (5.5%)IPD0 (0.0%)Reoperation rate4 (11.1%)Deceased4 (11.1%)Follow-up (months)67.3 (17–109)IPD Intraprosthetic dislocation Table 4Postoperative outcomesDislocation3 (8.3%)Aseptic loosening1 (2.7%)Periprosthetic fracture0 (0.0%)Periprosthetic joint Infection2 (5.5%)IPD0 (0.0%)Reoperation rate4 (11.1%)Deceased4 (11.1%)Follow-up (months)67.3 (17–109)IPD Intraprosthetic dislocation Postoperative outcomes IPD Intraprosthetic dislocation Discussion The main finding of this study is that cementing a DMC into a newly implanted PT shell yields significant improvements in HHS, LLD, and hip COR in patients with Paprosky type II and III defects at medium term outcomes. This approach combines the osteointegration potential of PT with the lower dislocation risk of dual mobility bearings. The management of severe acetabular bone defects aims to overcome bone loss, while restoring, as closely as possible the anatomical position of the COR [25] In this context, the reconstruction of the native acetabulum with the use of PT shell has emerged as a highly viable alternative, as it allows for both immediate primary stability and long-term biological fixation [26, 27]. Cementation of the DMC liner further allows fine intraoperative adjustment of COR height, offset, version and abduction within the limits of the cement mantle, independent of the exact position achieved by the press-fit shell, improving hip biomechanics [27, 28]. In our cohort, at a mean follow-up of 67.3 months (range, 17–109), 32 of 36 implants (88.9%) remained stable and well integrated with a single case (2.7%) meeting our radiographic criteria for loosening. Kaplan–Meier freedom from reintervention for any cause was 96.77% at both 12 and 24 months, 93.32% at 36 months, and 89.08% at 60 months. These results compare favorably with the available literature, most of which reports considerably shorter follow-up. Durable fixation without migration, osteolysis, or progressive radiolucency was reported by Gabor et al. in 38 hips at a mean of 7 months and Ballester et al. in 19 Paprosky type III revisions at a mean of 18 months [29, 30]. Del Gaizo et al. followed 37 Paprosky type IIIA revisions for a minimum of 2 years recording a single failure related to component migration exceeding 6 mm [31]. In the dual-mobility cohort of Brüggemann et al. (44 of 114 hips) followed for a mean of 4.9 years, the two re-revisions that occurred were both attributable to aseptic loosening at the tantalum shell–bone interface rather than at the cement–bearing interface [32]. Finally, Hitz et al. reported the longest follow-up of the available series recording no cup re-revision for either septic or aseptic loosening, with 8-year survivorship of 96.5% (95% CI 92–99) [33]. From a radiographic standpoint, the reconstruction restored a near-anatomical centre of rotation. The mean vertical distance of the centre of rotation from the inter-teardrop line decreased from 19.4 ± 14.9 mm to 3.8 ± 3.4 mm (p < 0.001) and the mean horizontal distance from the teardrop from 12.4 ± 9.9 mm to 3.8 ± 3.5 mm (p < 0.001), while limb-length discrepancy decreased from − 7.8 ± 20.6 mm to − 1.7 ± 5.6 mm, a reduction that did not reach statistical significance (p = 0.056). Restoration of the hip centre of rotation has been similarly reported by Ballester et al. (mean vertical position 3.5–1.4 cm) [30], and Hitz et al. who optimized it both vertically (48–34 mm) and horizontally, restoring an anatomical centre in 97.1% of hips per the Hirakawa criteria [33]. The radiographic restoration of the centre of rotation was accompanied by corresponding improvements in functional outcomes. The mean HHS in our cohort improved from 31.8 ± 12.0 to 87.0 ± 14.2 (p < 0.001), an increase comparable to those reported across the literature: from 33.0 to 81.5 by Del Gaizo et al. [31], from 47 to 81 by Chalmers et al. [34], from 50 to 78 by Gabor et al. [30], and from 36 to 82 by Hitz et al. [33] Interestingly, Valenzuela et al. compared dual-mobility with constrained bearings in rTHA and found the DMC group to achieve superior functional outcomes. The HHS was higher in the dual-mobility group preoperatively, by a mean of 14 points (95% CI − 1 to 27, P = 0.03), and this advantage persisted postoperatively at 12 months. Instability remains the most frequent complication after rTHA, and reduction of dislocation risk is the principal rationale for incorporating a dual-mobility bearing into the reconstruction [5, 35, 36]. A large diameter (> 36 mm) DMC is often used to manage and prevent instability after rTHA [37]. Cementing DMC into the TM shell allows further adjustments to accommodate shell position, abduction, and anteversion [30]. The dislocation rate in our series (8.3%, n = 3) remained within the range reported for comparable revision cohorts. The protective effect of dual mobility against instability is well supported across the cited series. Brüggemann et al. provided the most direct evidence, recording a single dislocation in the dual-mobility group (2.3%, n = 1/44) compared with the standard polyethylene group (20.0%, n = 14/70) [32]. Moreover, Valenzuela et al. found no instability in the dual-mobility group (0%, n = 0/25) against one subluxation with a constrained liner (4.0%, n = 1/25) [15]. Finally, Gabor et al. similarly reported only one dislocation (2.6%, n = 1/38), which occurred on the first postoperative day and was successfully managed with closed reduction [29]. Although pelvic discontinuity was not represented in our cohort, cementing a DMC into a cup-cage construct is an established option in the management of complex acetabular rTHAs. A cup-cage restores mechanical continuity across the defect but is limited by instability [28, 38]. Cementing a DMC into a cage or cup-cage therefore adds the dislocation resistance of a dual-mobility articulation to the mechanical stability of the cage. Cementation also decouples bearing orientation from shell position, a key advantage when host bone and flange fixation dictate an otherwise suboptimal cage position. In their work, Wilson et al. retrospectively reviewed 65 hips (64 patients) in which a monoblock DMC was cemented into a retained well-fixed acetabular component (n = 17, 36%), a newly implanted PT metal shell alone (n = 36; 55%), or a cup-cage construct (n= 12; 19%). Twenty of these hips (31%) had pelvic discontinuity. At two years, survival from any cemented DM-related complication and dislocation was 90% (95% CI 82 to 99) and 92% (95% CI 85 to 100), respectively. In total, there were 1 case of aseptic loosening and 5 cases of dislocation, 4 of which became intra-prosthetic dislocations during attempted closed reduction. All five cases of dislocation occurred in a patient who had either a pre-existing history of instability or abductor insufficiency. The mean two-year HHS was 71, with a mean improvement of 35 points [28]. Notably, the excellent outcomes of PT in rTHA contrast with the more variable results reported in other orthopaedic applications. In their work, Fokter et al. retrospectively compared the mid-term survival of 1,202 primary total knee arthroplasties (376 cementless with two-pegged Trabecular Metal modular tibial components vs. 826 cemented, all from the NexGen system, Zimmer Biomet, Warsaw, IN, USA) performed at a single high-volume center between 2017 and 2021. While 7-year all-cause survival did not differ between groups (97.4% cementless vs. 97.8% cemented, p = 0.63), aseptic survival was significantly lower in the cementless cohort (97.9% vs. 99.4%, p < 0.05), driven mainly by aseptic loosening of the tibial TM component (1.59% vs. 0.24%, p< 0.05). These concerns have been addressed by the authors to be “indication- and design-specific”, relating to the biomechanical demands of the tibial platform in primary TKA (e.g., increased tray stiffness, reduced bone–implant contact area, and insufficient osseointegration under high loads in younger active patients) rather than intrinsic limitations of the material itself. PT acetabular shells operate under distinct mechanical conditions, benefit from adjunctive screw fixation and augments, and continue to show favorable outcomes in acetabular revision, particularly in the Paprosky II–IIIB defect range addressed in the present study [39]. Several limitations of the present study should be acknowledged. First, its retrospective design and the absence of a control group prevented direct comparison of this technique’s outcomes with those of alternative reconstructive options for major acetabular bone loss. Second, the small sample size limits the statistical power of our findings and should be considered when interpreting the reported outcomes. Nevertheless, we included all eligible patients who underwent acetabular reconstruction with cementation of a DMC into a TM shell during the study period, minimizing selection bias within our cohort. These remain highly selected cases, reflecting the relatively rare and technically demanding nature of this severe acetabular bone defects, even at our institution, a high-volume tertiary referral center. All procedures were performed by a single, highly experienced surgeon. While this reduces operator-related variability and strengthens the internal consistency of our findings, it may also limit the generalizability of our results to lower-volume settings or less experienced surgeons. Longer follow-up and larger, ideally multicenter and controlled, studies are required to confirm the durability of this reconstruction and to determine whether cementation of a DMC into a TM shell represents the optimal technique for revising a failed acetabular component in the setting of major bone loss. Conclusions Cementation of a DMC into a porous tantalum cup combines the favorable biomechanical and osteointegration properties of porous tantalum with the reduced dislocation risk conferred by dual mobility. In our experience, this acetabular revision technique provided reliable immediate and long-term cup stability, effectively addressed hip instability, and yielded favorable clinical and radiographic outcomes at mid-term follow-up. Longer-term, comparative studies are warranted to confirm these findings and further define the role of this technique in the management of severe acetabular bone loss.